Cannabinoid receptors as therapeutic targets in the management of liver diseases.
about
Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells.Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in miceThe endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openingsCannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis.The direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptor.
P2860
Cannabinoid receptors as therapeutic targets in the management of liver diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cannabinoid receptors as therapeutic targets in the management of liver diseases.
@en
Cannabinoid receptors as therapeutic targets in the management of liver diseases.
@nl
type
label
Cannabinoid receptors as therapeutic targets in the management of liver diseases.
@en
Cannabinoid receptors as therapeutic targets in the management of liver diseases.
@nl
prefLabel
Cannabinoid receptors as therapeutic targets in the management of liver diseases.
@en
Cannabinoid receptors as therapeutic targets in the management of liver diseases.
@nl
P921
P1476
Cannabinoid receptors as therapeutic targets in the management of liver diseases.
@en
P2093
Ariane Mallat
P304
P356
10.1358/DNP.2008.21.7.1255306
P577
2008-09-01T00:00:00Z